DULIP: A Dual Luminescence-Based Co-Immunoprecipitation Assay for Interactome Mapping in Mammalian Cells
- PMID: 26264872
- DOI: 10.1016/j.jmb.2015.08.003
DULIP: A Dual Luminescence-Based Co-Immunoprecipitation Assay for Interactome Mapping in Mammalian Cells
Abstract
Mapping of protein-protein interactions (PPIs) is critical for understanding protein function and complex biological processes. Here, we present DULIP, a dual luminescence-based co-immunoprecipitation assay, for systematic PPI mapping in mammalian cells. DULIP is a second-generation luminescence-based PPI screening method for the systematic and quantitative analysis of co-immunoprecipitations using two different luciferase tags. Benchmarking studies with positive and negative PPI reference sets revealed that DULIP allows the detection of interactions with high sensitivity and specificity. Furthermore, the analysis of a PPI reference set with known binding affinities demonstrated that both low- and high-affinity interactions can be detected with DULIP assays. Finally, using the well-characterized interaction between Syntaxin-1 and Munc18, we found that DULIP is capable of detecting the effects of point mutations on interaction strength. Taken together, our studies demonstrate that DULIP is a sensitive and reliable method of great utility for systematic interactome research. It can be applied for interaction screening and validation of PPIs in mammalian cells. Moreover, DULIP permits the specific analysis of mutation-dependent binding patterns.
Keywords: detection of low- and high-affinity interactions; disease-mutation detection; luminescence normalization; quantitative interaction score and quantification of interaction strength; systematic protein–protein interaction screening.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Analysis of protein-protein interactions using LUMIER assays.Methods Mol Biol. 2013;1064:17-27. doi: 10.1007/978-1-62703-601-6_2. Methods Mol Biol. 2013. PMID: 23996247
-
Current Approaches Toward Quantitative Mapping of the Interactome.Front Genet. 2016 May 4;7:74. doi: 10.3389/fgene.2016.00074. eCollection 2016. Front Genet. 2016. PMID: 27200083 Free PMC article.
-
LUMIER: A Discovery Tool for Mammalian Protein Interaction Networks.Methods Mol Biol. 2017;1550:137-148. doi: 10.1007/978-1-4939-6747-6_11. Methods Mol Biol. 2017. PMID: 28188528
-
Interactome mapping for analysis of complex phenotypes: insights from benchmarking binary interaction assays.Proteomics. 2012 May;12(10):1499-518. doi: 10.1002/pmic.201100598. Proteomics. 2012. PMID: 22589225 Review.
-
Munc18-1 as a key regulator of neurosecretion.J Neurochem. 2010 Oct;115(1):1-10. doi: 10.1111/j.1471-4159.2010.06900.x. J Neurochem. 2010. PMID: 20681955 Review.
Cited by
-
Maximizing binary interactome mapping with a minimal number of assays.Nat Commun. 2019 Aug 29;10(1):3907. doi: 10.1038/s41467-019-11809-2. Nat Commun. 2019. PMID: 31467278 Free PMC article.
-
Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.Res Sq [Preprint]. 2020 May 13:rs.3.rs-28592. doi: 10.21203/rs.3.rs-28592/v1. Res Sq. 2020. PMID: 32702714 Free PMC article. Preprint.
-
LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells.Mol Syst Biol. 2018 Jul 11;14(7):e8071. doi: 10.15252/msb.20178071. Mol Syst Biol. 2018. PMID: 29997244 Free PMC article.
-
Modulation of Yorkie activity by alternative splicing is required for developmental stability.EMBO J. 2021 Feb 1;40(3):e104895. doi: 10.15252/embj.2020104895. Epub 2020 Dec 15. EMBO J. 2021. PMID: 33320356 Free PMC article.
-
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.Mol Syst Biol. 2024 Apr;20(4):428-457. doi: 10.1038/s44320-024-00019-8. Epub 2024 Mar 11. Mol Syst Biol. 2024. PMID: 38467836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials